GOPC:ROS1 and other ROS1 fusions represent a rare but recurrent drug target in a variety of glioma types

Acta Neuropathol. 2021 Dec;142(6):1065-1069. doi: 10.1007/s00401-021-02369-1. Epub 2021 Sep 18.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adaptor Proteins, Signal Transducing / genetics*
  • Brain Neoplasms / genetics*
  • Glioma / genetics*
  • Golgi Matrix Proteins / genetics*
  • Humans
  • Molecular Targeted Therapy
  • Oncogene Fusion / genetics
  • Oncogene Proteins, Fusion / genetics
  • Protein-Tyrosine Kinases / genetics*
  • Proto-Oncogene Proteins / genetics*

Substances

  • Adaptor Proteins, Signal Transducing
  • GOPC protein, human
  • Golgi Matrix Proteins
  • Oncogene Proteins, Fusion
  • Proto-Oncogene Proteins
  • Protein-Tyrosine Kinases
  • ROS1 protein, human